Generic semaglutide coverage in Canada: what each drug plan pays

Generic semaglutide coverage now exists on most provincial drug plans, but only for type 2 diabetes and only when you meet each plan’s criteria. If your plan paid for Ozempic before, it will likely pay for the generic, and it may push you toward it. This page walks through Ontario, Alberta, British Columbia, Quebec and the large private insurers, using each plan’s own documents.

Two things trip people up. Coverage is tied to a diagnosis, not to the drug, so the same pen can be covered for diabetes and refused for weight loss. And “covered” can mean “covered at the generic price,” which leaves you paying the gap if you insist on the brand.

Is generic semaglutide covered in Canada?

Yes, for adults with type 2 diabetes who meet a plan’s rules. Ontario, Alberta and BC have each put the generic on their public formulary. Every province’s public plan also covered brand Ozempic for diabetes before the generics arrived¹.

Here is the short version by plan. The details, and the documents behind them, follow.

None of this coverage depends on which generic your pharmacy has. A plan covers the molecule for a condition, and the pharmacist fills whichever interchangeable pen is in stock. With Dr. Reddy’s supply halted since July 2026, that is usually Apotex’s version².

Ontario ODB: generic semaglutide coverage under Limited Use

The Ontario Drug Benefit (ODB) program covers generic semaglutide as a Limited Use benefit for type 2 diabetes. It lists each generic pen at $78.14, and it pays that same amount when a pharmacy fills Ozempic³.

Who qualifies under ODB

Limited Use means your prescriber writes a reason-for-use code on the prescription. For semaglutide that code is 665, and the authorization period is indefinite, so there is no renewal form to chase^3,4.

The criteria cover adults with type 2 diabetes whose blood sugar stays high on the most metformin they can tolerate. People who cannot take metformin at all also qualify⁴.

ODB will not fund semaglutide together with another GLP-1 drug or a DPP-4 inhibitor. It also will not pay for the injection and the oral tablet at the same time, and it covers only one dosage format⁴.

What ODB pays for each pen

The generics went on the formulary on June 30, 2026. Ontario lists them as interchangeable with Ozempic³.

Interchangeable is the word that matters here. It lets your pharmacist hand you a generic on an Ozempic prescription, and it lets the plan cap its payment at the generic price.

Ozempic’s own Drug Benefit Price on the formulary is $227.94. But the column for what the Ministry of Health pays reads $78.14 for Ozempic too, about 34% of the brand’s list price³.

Our read: if you stay on the brand through ODB, ask your pharmacist up front who pays the gap. The formulary does not say the brand is off limits, only that the plan’s payment stops at the generic price.

Which pens are grouped together

Ontario groups each generic with the Ozempic pen that has the same concentration³. Apotex’s 0.25/0.5 mg pen (0.68 mg/mL) sits with Ozempic DIN 02540258. The Dr. Reddy’s 0.25/0.5 mg pen (1.34 mg/mL, 1.5 mL) sits with Ozempic DIN 02471477, and the three 1 mg pens from Novo, Apotex and Dr. Reddy’s form their own group.

That grouping is why a pharmacist will not swap any pen for any other. The substitute has to match the strength and concentration on your prescription. One note: the Ozempic pen in the Dr. Reddy’s group, DIN 02471477, has been listed as dormant in Health Canada’s database since July 24, 2026⁵.

Alberta: generic semaglutide coverage on the benefit list

Alberta added generic semaglutide to its Drug Benefit List on July 1, 2026, for type 2 diabetes. The generic is listed as interchangeable with Ozempic and carries the same coverage criteria⁶.

In the bulletin announcing the listing, Alberta Blue Cross told pharmacies the generic “is considered equally safe and effective as Ozempic”⁶. Before this, Alberta covered Ozempic only through special authorization, and only after other diabetes drugs⁷.

The Least Cost Alternative pause

Alberta planned to apply its Least Cost Alternative (LCA) rule after a 30-day transition. Under LCA, a person who chose Ozempic over the generic would pay the price difference⁶.

That plan stalled when Dr. Reddy’s reported a shortage on July 10, 2026. Alberta then postponed LCA pricing and stretched the transition “until the supply of generic semaglutide products has stabilized”². Our read: if you are on a government-sponsored Alberta plan and still on Ozempic, the switch rule is coming, just not yet.

Alberta Blue Cross private plans

Alberta Blue Cross moved faster on the private plans it runs. From August 17, 2026, it began paying Ozempic claims at the generic price on private plans that follow generic pricing⁸. The LCA pause stayed in place for the government-sponsored programs⁸.

British Columbia: Special Authority

BC PharmaCare covers semaglutide for type 2 diabetes through Special Authority (SA). It added the Apotex and Dr. Reddy’s generics to the formulary effective June 15, 2026^9,10.

BC’s criteria

The SA criteria call for poor blood-sugar control on the highest metformin dose you can tolerate. BC suggests trying metformin for at least three months first⁹. Coverage goes up to 1 mg weekly with no end date, and a patient who meets the criteria can be approved automatically⁹.

BC covers either semaglutide or an eligible DPP-4 inhibitor, not both. Approval for semaglutide ends coverage of the DPP-4 drug. BC also will not pay for two 0.5 mg doses from a 0.5 mg pen to reach 1 mg⁹.

What changed on June 15

BC’s June 2026 PharmaCare Newsletter listed the Apotex and Dr. Reddy’s pens, by DIN, for type 2 diabetes after metformin. The generics went into BC’s Low Cost Alternative program with full coverage through an SA request¹⁰. Trade press reported the same change two days later¹¹.

Here is the part that differs from Ontario. To support supply stability, BC said Ozempic “will remain fully covered through SA request”¹⁰. So, as of that newsletter, a BC patient on Ozempic was not pushed off the brand.

BC also said the generics are priced at a 65% discount to Ozempic¹⁰. If Fair PharmaCare covers your drugs, your share still depends on whether you have met your deductible or family maximum for the year¹⁰.

The 2 mg dose and BC’s cost figure

BC’s September 2026 diabetes drug table lists “OZEMPIC, generics” as Limited Coverage at about $85 a pen. It marks the 2 mg dose as a non-benefit¹².

BC’s criteria page, last updated in April, says the 2 mg dose is under review⁹. No generic comes in a 2 mg dose anyway⁵.

Quebec (RAMQ): what is confirmed

Quebec’s public plan offers generic semaglutide, but the RAMQ listing details are not confirmed here. The only citable statement is from a McGill University study in the Canadian Journal of Cardiology¹³.

That study says the generic is “now available through Quebec’s public drug plan.” It puts the yearly cost at about $1,060, dispensing fees included¹³. It is a researcher’s cost figure, not a RAMQ price list.

This page could not confirm the listing date, unit price or any “médicament d’exception” criteria on RAMQ’s own list. Treat those details as unconfirmed.

One Quebec rule is clear. Novo Nordisk’s Ozempic Savings Card cannot be used in Quebec, which Novo puts down to provincial regulations^14,15. A Quebec patient comparing brand and generic cannot use the card to close the gap.

Other provinces and territories

Every province and territory already covered brand Ozempic for type 2 diabetes through its public plan, according to The Globe and Mail¹. Generic semaglutide coverage in those other provinces comes down to each plan’s own timing. Each one decides when to list the generic and whether to make it interchangeable.

Private insurers wait for those rulings. Medavie Blue Cross says it switches on generic substitution once a province confirms the generic can be substituted for Ozempic¹⁶.

Outside the four provinces above, check your provincial formulary. Or ask your pharmacist whether the generic is listed as interchangeable where you live.

Private insurance and mandatory generic substitution

Many private plans now pay for Ozempic only at the generic price. The trigger is a provincial interchangeability ruling, and after it your plan either switches you or reimburses at the generic rate^1,16.

What Medavie Blue Cross says

Medavie’s member FAQ is dated June 18, 2026. It spells out the rules¹⁶:

• It turns on generic substitution once provinces confirm the generic is substitutable.
• Members whose plans have mandatory generic substitution pay the cost difference to stay on Ozempic.
• Writing “no substitution” on the prescription does not get around that rule.
• A member can ask for an exception if they have an adverse effect on the generic.
• Generic Ozempic “will not be approved as a substitute” for Wegovy.

That third point catches people out. Many patients expect a doctor’s “no substitution” note to protect the brand. Under Medavie’s mandatory substitution rule it does not, unless an exception is approved.

Manulife and Sun Life

Manulife and Sun Life told The Globe and Mail that provinces have to rule on interchangeability first¹. After that, members would be switched to the generic or reimbursed at the generic price¹.

Where the Ozempic Savings Card fits

On July 6, 2026, Novo Nordisk extended its Ozempic Savings Card to people with private coverage, outside Quebec¹⁷. The card does not apply when a public plan covers your Ozempic¹⁴.

If your private plan now pays only the generic price, the card is one way to stay on the brand. Our savings card guide covers how it works.

Is semaglutide covered for weight loss?

No. No public drug plan in Canada covers semaglutide for weight management, whether the brand Wegovy or the generic Sevmia.

The pan-Canadian Pharmaceutical Alliance (pCPA), which negotiates for the public plans, closed its Wegovy file on December 1, 2025 “without agreement (manufacturer declined negotiations)”¹⁸. Novo told pCPA it would stop seeking public coverage of Wegovy in Canada, and Global News reported the same^18,19.

BC lists Wegovy as a non-benefit, in a decision dated December 18, 2025¹⁸. In the same decision, BC said it would review generic semaglutide submissions “for all approved indications” once those products reach the market¹⁸. It is a promise to look, not a promise to cover.

Ontario lists both Wegovy and Sevmia as “Off-Formulary Interchangeable,” which means neither is an ODB benefit³. Private plans vary, and some cover weight-management drugs.

Medavie will not approve generic Ozempic as a stand-in for Wegovy¹⁶. For what Sevmia is and where it stands, see the generic Wegovy guide.

What you pay without coverage

If no plan pays, you pay cash, and the generic is far cheaper than the brand. CBC reported in May 2026 that pharmacies had cut the monthly cost to “roughly $100”²⁰.

Counter prices start at $92 at Costco Pharmacy, using figures from a published August 2026 retail audit or labelled estimates. The full pharmacy price comparison shows every chain, with fees.

How to check your own generic semaglutide coverage

Five steps will tell you where you stand. Most people can finish them with one call to their plan and one to their pharmacy.

1. Find your plan’s name and number. Look on your benefits card or provincial health plan papers. Public and private plans can both apply, and the order they pay in matters.
2. Get the DIN on your prescription. Ask your pharmacist for the Drug Identification Number of your pen. Plans check coverage by DIN. The generic and the brand have different ones.
3. Ask about generic substitution. Ask your insurer three things. Does the plan cover semaglutide for type 2 diabetes? Does it have mandatory generic substitution? What will you pay if you stay on Ozempic?
4. Have your prescriber handle the forms. Ontario’s Limited Use code, BC’s Special Authority and private exception requests all go through the prescriber. If you had an adverse effect on the generic, say so; Medavie names that as grounds for an exception¹⁶.
5. Price the gap. If the plan pays only the generic price, compare that with your copay on the brand. Outside Quebec, compare it with the savings card too.

If your pen is the Dr. Reddy’s product, note that its supply has been halted since July 2026, and your pharmacy may fill an interchangeable Apotex pen instead. The Dr. Reddy’s semaglutide page explains what happened.

Which generic semaglutide coverage route fits you

Coverage answers depend on who you are, so here is how it shakes out. These are our reads of the plan documents above, not plan rulings.

• Type 2 diabetes, public plan in Ontario or Alberta: you are likely covered for the generic. Staying on Ozempic may cost you the difference, now in Ontario and later in Alberta once LCA resumes.
• Type 2 diabetes, BC PharmaCare: the generic is covered by Special Authority, and Ozempic was still fully covered as of June 2026. Your Fair PharmaCare deductible still applies.
• Type 2 diabetes, Quebec: the generic is offered on the public plan, but confirm the details with your pharmacist. The savings card does not work there.
• Private plan: ask whether your plan has mandatory generic substitution. If it does, the generic is the cheapest way to stay covered.
• Weight loss, any province: no public plan pays. Check whether your private plan covers weight-management drugs, or compare cash prices.

If you have no coverage at all, the route comes down to price and convenience. Answer three questions in our route finder to see which pharmacy or online option fits where you live.